BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38085929)

  • 21. Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study.
    Xia K; Zhang L; Zhang G; Wang Y; Huang T; Fan D
    Orphanet J Rare Dis; 2021 Dec; 16(1):508. PubMed ID: 34906191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causal Associations Between Lifestyle Habits and Risk of Benign Prostatic Hyperplasia: A Two-Sample Mendelian Randomization Study.
    Jia F; Wei Z; Kong X; Mao Y; Yang Y
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37526403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer.
    Wu X; Hu C; Wu T; Du X; Peng Z; Xue W; Chen Y; Dong L
    Hum Genomics; 2024 Jun; 18(1):56. PubMed ID: 38831447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicted leukocyte telomere length and risk of myeloid neoplasms.
    Sullivan SM; Cole B; Lane J; Meredith JJ; Langer E; Hooten AJ; Roesler M; McGraw KL; Pankratz N; Poynter JN
    Hum Mol Genet; 2023 Oct; 32(20):2996-3005. PubMed ID: 37531260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis.
    Chen M; Xu Y; Xu J; Chancoco H; Gu J
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):203-209. PubMed ID: 32998948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study.
    Rodriguez-Martin I; Villanueva-Martin G; Guillen-Del-Castillo A; Ortego-Centeno N; Callejas JL; Simeón-Aznar CP; Martin J; Acosta-Herrera M
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.
    Glaser A; Shi Z; Wei J; Lanman NA; Ladson-Gary S; Vickman RE; Franco OE; Crawford SE; Lilly Zheng S; Hayward SW; Isaacs WB; Helfand BT; Xu J
    Eur Urol Open Sci; 2022 Sep; 43():54-61. PubMed ID: 36353071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Leukocyte Telomere Length Is Associated with Increased Risks of Soft Tissue Sarcoma: A Mendelian Randomization Study.
    Xu Y; Xu J; Chancoco H; Huang M; Torres KE; Gu J
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.
    Gao Y; Wang T; Yu X; ; Zhao H; Zeng P
    Sci Rep; 2020 Jul; 10(1):12184. PubMed ID: 32699404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causal pathway from telomere length to occurrence and 28-day mortality of sepsis: an observational and mendelian randomization study.
    Jiang T; Mo X; Zhan R; Zhang Y
    Aging (Albany NY); 2023 Aug; 15(15):7727-7740. PubMed ID: 37543429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic association of leukocyte telomere length with Graves' disease in Biobank Japan: A two-sample Mendelian randomization study.
    Ye M; Wang Y; Zhan Y
    Front Immunol; 2022; 13():998102. PubMed ID: 36248806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank.
    Wang Q; Codd V; Raisi-Estabragh Z; Musicha C; Bountziouka V; Kaptoge S; Allara E; Angelantonio ED; Butterworth AS; Wood AM; Thompson JR; Petersen SE; Harvey NC; Danesh JN; Samani NJ; Nelson CP
    EBioMedicine; 2021 Aug; 70():103485. PubMed ID: 34304048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of shorter leucocyte telomere length with risk of frailty.
    Bountziouka V; Nelson CP; Codd V; Wang Q; Musicha C; Allara E; Kaptoge S; Di Angelantonio E; Butterworth AS; Thompson JR; Curtis EM; Wood AM; Danesh JN; Harvey NC; Cooper C; Samani NJ
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1741-1751. PubMed ID: 35297226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
    Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
    HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does physical activity moderate the association between shorter leukocyte telomere length and incident coronary heart disease? Data from 54,180 UK Biobank participants.
    Xiang M; Pilling LC; Melzer D; Kirk B; Duque G; Liu R; Kuchel GA; Wood AR; Metcalf B; Diniz BS; Hillsdon M; Kuo CL
    Geroscience; 2024 Feb; 46(1):1331-1342. PubMed ID: 37544968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients.
    Tsai CW; Chang WS; Xu J; Xu Y; Huang M; Pettaway C; Bau DT; Gu J
    Carcinogenesis; 2020 Sep; 41(9):1213-1218. PubMed ID: 32614411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of telomere length with risk of lung cancer: A large prospective cohort study from the UK Biobank.
    Han D; Zhu Y; Choudhry AA; Cheng J; Liang H; Lin F; Chang Q; Liu H; Pan P; Zhang Y
    Lung Cancer; 2023 Oct; 184():107358. PubMed ID: 37696218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women.
    Schuermans A; Nakao T; Uddin MM; Hornsby W; Ganesh S; Shadyab AH; Liu S; Haring B; Shufelt CL; Taub MA; Mathias RA; Kooperberg C; Reiner AP; Bick AG; Manson JE; Natarajan P; Honigberg MC
    Circ Res; 2023 Aug; 133(5):376-386. PubMed ID: 37489536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The causal relationship between genetically determined telomere length and meningiomas risk.
    Yu W; Mei Y; Lu Z; Zhou L; Jia F; Chen S; Wang Z
    Front Neurol; 2023; 14():1178404. PubMed ID: 37693759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.